Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (494)	1/12/1998 2:26:00 PM
From: tonyt	Read Replies (1) \| Respond to of 1972

UP 13/16ths at 13 5/8's -- I can't wait to see what happens on a good market day!

To: Scott H. Davis who wrote (494)	1/12/1998 9:50:00 PM
From: William Strop	Respond to of 1972

Scott, I never give advice --- it's just that misery likes company --- but after being absent for a month I picked quite a day to show up!!! Anyway -- good luck. Regarding the Murphy recommendation & statement re: Merck announcong FDA approval--- here's my two cents. Merck started the Influenza vaccine Phase I trial around 5/1/96. They have since completed it but no results have been announced. The only mention I ever found re: the Aids vaccine was a briefing from the President of Merck to a Congressional Task Force on 6/23/97. He stated that they had licensed the technology from Vical & that Merck's Aids vaccine was in Pre-clinical status. So Murphy is likely referring to Merck announcing FDA approval to enter Phase I testing. Other information I have gotten from brokerage analysis in the past indicate an approximate date of 2002 for actual products (if any). fwiw, Bill